James Brady
Fortune : 929 615 $ au 31/08/2026
Fortune : 929 615 $ au 31/08/2026
James P.
Brady is currently Chief Human Resources Officer at Ardelyx, Inc. since 2025.
Formerly, Mr. Brady was Chief Human Resources Officer at Spero Therapeutics, Inc., Vice President-Human Resources at Intarcia Therapeutics, Inc. from 2015 to 2020, and Chief Human Resources Officer at uniQure NV from 2020 to 2021.
Education includes graduate studies at Harvard University and undergraduate studies at Marietta College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARDELYX, INC. 0,1 % | 21/08/2026 | 245 930 ( 0,1 % ) | 929 615 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ARDELYX, INC. | Responsable des Ressources Humaines | 02/06/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| UNIQURE N.V. | Responsable des Ressources Humaines | 01/09/2021 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Responsable des Ressources Humaines | 01/08/2020 |
| SPERO THERAPEUTICS, INC. | Responsable des Ressources Humaines | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marietta College
Marietta College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national